tiprankstipranks
Trending News
More News >
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market
Advertisement

Denali Therapeutics (DNLI) Ownership - Who Owns Denali Therapeutics?

Compare
737 Followers

Denali Therapeutics (DNLI) Ownership Overview

7.26%32.51%31.43%14.32%14.48%
31.43% Other Institutional Investors
14.32% ETFs
14.48% Public Companies and
Individual Investors
The ownership structure of Denali Therapeutics (DNLI) stock is a mix of institutional, retail, and individual investors. Approximately 78.26% of the company’s stock is owned by Institutional Investors, 7.26% is owned by Insiders, and 14.48% is owned by Public Companies and Individual Investors.
The ownership structure of Denali Therapeutics (DNLI) stock is a mix of institutional, retail, and individual investors. Approximately 63.94% of the company’s stock is owned by Institutional Investors, 7.26% is owned by Insiders, and 14.32% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 14, 2025
xxxxxxxxxxxxx
$39884
Aug 14, 2025
xxxxxxxxxxxxx
$39884
Jan 08, 2025
xxxxxxxxxxxxx
$308291
Jan 08, 2025
xxxxxxxxxxxxx
$308291

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$906538
Jun 30, 2025
xxxxxxxxxxxxx
$21208714

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,727,885Institution7.34%157,699,910
10,627,947Institution7.27%156,230,821
10,107,578Institution6.91%148,581,397
5,851,241Institution4.00%86,013,243
3,731,695Institution2.55%54,855,917
3,432,149Institution2.35%50,452,590
3,415,958Insider2.34%50,214,583
3,370,076Institution2.30%49,540,117
2,455,675Insider1.68%36,098,423
2,284,695Institution1.56%33,585,017

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,727,885Institution7.34%157,699,910
10,107,578Institution6.91%148,581,397
3,432,149Institution2.35%50,452,590
3,370,076Institution2.30%49,540,117
2,284,695Institution1.56%33,585,017
1,842,941Institution1.26%27,091,233
1,422,647Institution0.97%20,912,911
1,314,039Institution0.90%19,316,373
1,262,958Institution0.86%18,565,483
1,024,429Institution0.70%15,059,106

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,728,084Institution2.55%51,559,402
3,158,514Institution2.16%46,430,156
2,818,757Institution1.93%38,983,409
1,580,052Institution1.08%21,852,119
1,550,088Institution1.06%22,414,272
1,336,149Institution0.91%18,478,941
1,096,381Institution0.75%16,116,801
777,490Institution0.53%11,429,103
631,274Institution0.43%8,730,519
590,793Institution0.40%8,542,867

FAQ

Who Owns Denali Therapeutics (DNLI)?
According to the latest TipRanks data, approximately 31.43% of the company's stock is held by institutional investors, 7.26% is held by insiders, and 14.48% is held by retail investors.
    What percentage of Denali Therapeutics (DNLI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 31.43% of Denali Therapeutics (DNLI) stock is held by institutional investors.
      What percentage of Denali Therapeutics (DNLI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.48% of Denali Therapeutics (DNLI) stock is held by retail investors.
        Who owns the most shares of Denali Therapeutics (DNLI)?
        VANGUARD SPECIALIZED FUNDS owns the most shares of Denali Therapeutics (DNLI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis